ALVO OAKTREE ACQUISITION CORP II

Transactions of Managers and Closely Associated Persons

Transactions of Managers and Closely Associated Persons

Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition at the market opening of 320,000 shares in Alvotech at ISK 1,255 per share, by Robert Wessman, Chairman and CEO.



EN
09/05/2025

Underlying

ALVOOAKTREE ACQUISITION CORP II

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OAKTREE ACQUISITION CORP II

 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech Meets Investors and Participates in Fireside Chat At the Bof...

Alvotech Meets Investors and Participates in Fireside Chat At the BofA Securities Healthcare Conference 2025 in Las Vegas, Nevada   Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the BofA Securities Healthcare Conference 2025, which will be held in Las Vegas, Nevada, May 13-15, 2025. Members of the management team will host one-on-one meetings at the conference. Alvotech will also be participating in a fireside chat on Wednesday, May 14, 2025, at 11:40 am...

May 9, 2025 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech fundar með fjárfestum á heilbrigðisráðstefnu BofA Securities ...

Alvotech fundar með fjárfestum á heilbrigðisráðstefnu BofA Securities í Las Vegas og situr fyrir svörum Alvotech (NASDAQ: ALVO) tekur þátt í árlegri heilbrigðisráðstefnu BofA Securities í Las Vegas, Nevada sem haldin verður í dagana 13.–15. maí nk. Fulltrúar félagsins funda með fjárfestum og sitja fyrir svörum hjá greinanda bankans á heilbrigðissviði, miðvikudaginn 14. maí nk. kl. 15:40–16:10. Hægt verður að hlýða á hljóðupptöku af samtalinu við greinanda BofA Securities í beinu streymi. Þá verður upptaka aðgengileg á vefsíðu félagsins í 90 daga eftir að ráðstefnunni lýkur. Upplýsingar um ...

May 9, 2025 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech Meets Investors and Participates in Fireside Chat At the BofA...

Alvotech Meets Investors and Participates in Fireside Chat At the BofA Securities Healthcare Conference 2025 in Las Vegas, Nevada REYKJAVIK, Iceland, May 09, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the BofA Securities Healthcare Conference 2025, which will be held in Las Vegas, Nevada, May 13-15, 2025. Members of the management team will host one-on-one meetings at the conference. Alvotech will also be participating in a fi...

May 9, 2025 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Transactions of Managers and Closely Associated Persons

Transactions of Managers and Closely Associated Persons Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition at the market opening of 320,000 shares in Alvotech at ISK 1,255 per share, by Robert Wessman, Chairman and CEO.

May 9, 2025 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Viðskipti stjórnenda og tengdra aðila

Viðskipti stjórnenda og tengdra aðila Í viðhengi er tilkynning um viðskipti stjórnenda og tengdra aðila sem send var inn til fjármálaeftirlits Lúxemborgar, Luxembourg Commission de Surveillance du Secteur Financier (CSSF), varðandi kaup Róberts Wessmans, stjórnarformanns og forstjóra Alvotech við opnun markaðarins í dag á 320.000 hlutum í Alvotech á genginu 1.255 kr. Viðhengi

May 9, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch